A new agreement between the University of Houston and India will establish the UH-DGH Data Center. Photo via UH.edu

The University of Houston has signed an agreement with India to bring a data center focused on energy to campus, the school announced last week.

The memorandum of understanding, or MoU, is between UH and the Directorate General Hydrocarbon, the technical arm of the Indian Ministry of Petroleum and Natural Gas The agreement is to establish the UH-DGH Data Center, which, according to a UH press release, "will house a geoscience data repository with display capability and software to interpret key exploration and production data and extensive knowledge of India’s sedimentary basins and fields."

The five-year agreement aims to generate reliable information on the energy industry — including seismic, well, reservoir and production data.

“This MoU is essentially an agreement to spur collaboration and combine the strengths of the involved parties for greater good,” says Ramanan Krishnamoorti, vice president of energy and innovation at UH, in the release. “UH is in Houston, the Energy Capital of the World and the DGH has this wonderful wealth of information in its National Data Repository.

"By working together, we will maximize the potential of this important data and it will serve as an excellent research foundation,” he continues.

Krishnamoorti signed the agreement on behalf of UH and Akash Goyal, addl. director general – coordination represented DGH.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.